Medpace Holdings, Inc.
MEDP
株式のランク
#1303
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
株価
$622.03
最終同期: 2026-10-20
時価総額
$17.36B
変化（1日）
0.38%
変化（1年）
14.00%
国
US
取引 Medpace Holdings, Inc. (MEDP)
カテゴリー
Healthcare
Medpace Holdings, Inc.（MEDP）の利益
Jun 2026 時点の利益 TTM: $598.92M
Medpace Holdings, Inc. の最新の財務報告によると、同社の現在の利益は $598.92M です。2024 年には $475.92M の利益を上げ、これは 2023 年の利益 $335.68M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Medpace Holdings, Inc. の利益の推移（2013 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $598.92M | 10.43% |
| 2025 | $542.38M | 13.96% |
| 2024 | $475.92M | 41.78% |
| 2023 | $335.68M | 18.67% |
| 2022 | $282.86M | 40.13% |
| 2021 | $201.85M | 19.77% |
| 2020 | $168.53M | 35.01% |
| 2019 | $124.83M | 32.87% |
| 2018 | $93.95M | 64.99% |
| 2017 | $56.95M | 159.35% |
| 2016 | $21.96M | -380.42% |
| 2015 | $-7.83M | -63.17% |
| 2014 | $-21.26M | -154.31% |
| 2013 | $39.15M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.61B | 1,170.45% |
US
|
|
| $4.76B | 695.09% |
US
|
|
| $-252.70M | -142.19% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 176.83% |
US
|
